UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$234M |
| 2 |
Home Depot
HD
|
+$214M |
| 3 |
Intercontinental Exchange
ICE
|
+$206M |
| 4 |
TJX Companies
TJX
|
+$129M |
| 5 |
BorgWarner
BWA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$227M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$212M |
| 3 |
Mohawk Industries
MHK
|
+$137M |
| 4 |
Liberty Global Class A
LBTYA
|
+$114M |
| 5 |
Freeport-McMoran
FCX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.05% |
| 2 | Technology | 13.96% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 9.13% |
| 5 | Energy | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
AGNC Investment
AGNC
$12.4B
| $24.7M | 0.02% |
1,053,426
+39,840
| +4% | +$916K |
|
|
SNI
602
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $24.6M | 0.02% |
303,438
+6,362
| +2% | +$487K |
|
603
New Oriental
EDU
$9.39B
| $24.5M | 0.02% |
923,800
-223,900
| -20% | -$5.78M |
|
604
W.R. Berkley
WRB
$26.7B
| $24.4M | 0.02% |
1,775,345
-80,655
| -4% | -$1.05M |
|
605
Royal Caribbean
RCL
$87B
| $24.3M | 0.02% |
437,151
-13,279
| -3% | -$715K |
|
|
CHL
606
DELISTED
China Mobile Limited
CHL
| $24.2M | 0.02% |
497,428
+772
| +0.2% | +$37K |
|
607
Jacobs Solutions
J
$16.3B
| $24.1M | 0.02% |
546,363
-177,337
| -25% | -$8.44M |
|
608
A.O. Smith
AOS
$8.21B
| $24M | 0.02% |
967,080
+99,736
| +11% | +$2.39M |
|
|
CIT
609
DELISTED
CIT Group Inc.
CIT
| $23.9M | 0.02% |
521,388
+1,140
| +0.2% | +$51.4K |
|
610
Flex
FLEX
$42.3B
| $23.9M | 0.02% |
2,859,363
+344,989
| +14% | +$2.6M |
|
|
BEAV
611
DELISTED
B/E Aerospace Inc
BEAV
| $23.8M | 0.02% |
355,802
+17,405
| +5% | +$1.16M |
|
|
612
Liberty Global Class A
LBTYA
$3.71B
| $23.8M | 0.02% |
653,309
-3,247,222
| -83% | -$114M |
|
613
News Corp Class A
NWSA
$15.1B
| $23.7M | 0.02% |
1,320,796
-42,877
| -3% | -$740K |
|
|
ARG
614
DELISTED
Airgas Inc
ARG
| $23.7M | 0.02% |
217,474
+10,300
| +5% | +$1.1M |
|
615
Quanta Services
PWR
$101B
| $23.6M | 0.02% |
682,035
+23,929
| +4% | +$828K |
|
|
CYT
616
DELISTED
CYTEC INDS INC
CYT
| $23.6M | 0.02% |
446,952
+21,730
| +5% | +$1.07M |
|
617
Xylem
XYL
$27.8B
| $23.3M | 0.02% |
596,175
+3,486
| +0.6% | +$130K |
|
618
Universal Health Services
UHS
$10.4B
| $23.3M | 0.02% |
243,043
-3,985
| -2% | -$344K |
|
619
Pultegroup
PHM
$24.4B
| $23.2M | 0.02% |
1,148,340
-205,111
| -15% | -$3.94M |
|
620
Innoviva
INVA
$1.53B
| $22.9M | 0.02% |
770,397
-158,488
| -17% | -$3.8M |
|
|
ADT
621
DELISTED
ADT Corp
ADT
| $22.9M | 0.02% |
655,694
-4,153
| -0.6% | -$133K |
|
|
AMTD
622
DELISTED
TD Ameritrade Holding Corp
AMTD
| $22.7M | 0.02% |
723,692
+44,369
| +7% | +$1.38M |
|
|
DNR
623
DELISTED
Denbury Resources, Inc.
DNR
| $22.6M | 0.02% |
1,226,896
+20,515
| +2% | +$352K |
|
624
D.R. Horton
DHI
$40.6B
| $22.6M | 0.02% |
920,316
+14,387
| +2% | +$329K |
|
|
TGNA
625
DELISTED
TEGNA Inc
TGNA
| $22.4M | 0.02% |
1,369,003
-218,231
| -14% | -$3.2M |
|
Similar funds
UBS AM's Q2 2014 Portfolio in Review
As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
- UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
- UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
- UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
- UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
- UBS AM opened 81 new positions and closed 97 in Q2 2014.
- UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.
Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.